Wednesday, 25 February 2026
At the 2026 JP Morgan Healthcare Conference, CytoReason unveiled LINA, an AI agent designed to support pharmaceutical research and development. LINA is a computational biology assistant that interprets molecular, clinical, and patient-level data using CytoReason's AI disease models and NVIDIA NIM microservices. Built on CytoReason's AI framework and trained on hundreds of drug-dev
TetraScience, the Scientific Data and AI company, announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a goal of accelerating AI across biopharma R&D and manufacturing by transforming scientific data into AI-native form and developing intelligent workflows at scale. As the complexity and cost of bringing new therapies to market continue to ri
Basecamp Research, a frontier AI lab harnessing evolution to design new medicines, announced the first AI models capable of programmable gene insertion, offering a new way to replace faulty genes and reprogram cells for therapeutic use. Trained in collaboration with NVIDIA, these models are driving the development of a new generation of treatments for cancer and inherited diseases. In parallel, Ba
Doceree, the world's first AI-powered Operating System for healthcare marketing, today announced its emergence as the most AI-forward technology platform in the category, marking 2025 as the year it moved the industry from fragmented AI adoption to AI-native execution at scale. As healthcare marketing crossed a critical inflection point in 2025, Doceree didn't merely deploy arti
Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, announced an integrated drug discovery collaboration to identify and develop novel small-molecule drug candidates in oncology. This initiative reflects both companies' commitment to advancing oncology research by integrating complementary strengths across computational design,
CytoReason, a leader in AI-powered computational disease modeling, announced the expansion of its collaboration with Sanofi for the third time. This multi-year agreement, valued at up to $16 million, further solidifies their partnership. CytoReason technology enables researchers to extract insights from molecular and clinical data, empowering R&D teams across the organization to leverage scie
A recent survey by Life Times, a well-known Chinese public health media outlet, shows that AI doctor services are broadly supported by doctors in China. Among 500 physicians from the country’s top-tier (tertiary) hospitals, more than 70% said they would recommend AI doctor services to patients for everyday health questions and routine health management. Ant Group
Fixstars Corporation (TSE Prime: 3687, US Headquarters: Irvine, CA), a leading company in performance engineering technology, announced the release of the latest version of its AI processing acceleration platform, "Fixstars AIBooster" (hereinafter "AIBooster"). The latest version of AIBooster introduces enhanced flexibility and deeper diagnostic capabilities: advanced diagnostic reports f
Net Health, a leader for specialized software solutions that deliver intelligent, human-centered technology to post-acute and senior living healthcare providers, announced the launch of Optima Unity, a secure, web-based user experience that uses native artificial intelligence (AI) to significantly improve clinical efficiency and provide intelligent documentation that saves time, increases acc
Skylight Health, a mission-driven healthcare company committed to Making Specialty Care Better for All, announced the acquisition of Stellation Care. Stellation is a provider analytics company that leverages AI-augmented datasets and advanced algorithms to deliver provider intelligence and referral optimization insights for health plans and risk-bearing provider groups. This strategic transa
Vastnaut, a wearable robotics pioneer, introduced the world's first AI-powered 4x4 exoskeleton for the toughest terrain. Its first product aims to assist outdoor enthusiasts and professionals in conquering the planet's most rugged and extreme landscapes, inspiring them to explore with amplified strength, confidence, and freedom. A Structural Innovation in Consumer ExoskeletonVastnaut prou
Eros Innovation, a global artificial intelligence and intellectual-property company, announced a landmark collaboration between its AI-driven health platform Eros LifeScience and the Centre for Cancer Epidemiology (CCE), Tata Memorial Centre (TMC), Mumbai, to launch Gujarat CARES 2025 - a historic, population-scale preventive health initiative.As one of India’s foremost AI companie
AIdMD Technologies is pleased to announce the U.S. market launch of its artificial intelligence–powered healthcare platform, introducing a modern approach to clinical documentation, decision support, and workflow efficiency designed for real-world medical environments. The announcement marks the formal availability of the company’s two core products, AIdMD EHR and AIdMD Insig
In the rapidly evolving aesthetic and dermatological sectors, the demand for precise and reliable diagnostic tools is becoming increasingly critical. Shanghai May Skin Information Technology Co., Ltd., a key player in intelligent beauty equipment, emphasizes that its MEICET-branded devices represent some of the best professional skin analyzer products available globally, particularly in
The year 2025 saw an unprecedented flurry of mergers and acquisitions across the AI and technology sectors, as companies raced to acquire strategic capabilities, talent, and infrastructure. Major tech firms and startups alike moved aggressively to expand their AI-related portfolios, blurring lines between traditional categories. For example, renewables and infrastructure became part of AI strategy
Mental health has become the defining workplace challenge of our generation. Nearly one in five adults’ lives with a mental health condition, while depression and anxiety cost the global economy over $1 trillion annually in lost productivity. Traditional Employee Assistance Programs see utilization rates of just 3-5%, leaving a critical gap between the support people need and what they
Penguin Ai, a health care artificial intelligence (AI) company, announced a collaboration with FTI Consulting, Inc. (NYSE: FCN), a global business advisory firm, to help healthcare providers strengthen revenue cycle performance and reduce administrative burden. By integrating Penguin Ai's platform into FTI Consulting's revenue cycle management (RCM) transformation work, the collaboration will
b.well Connected Health, the most connected digital health platform for AI-powered consumer experiences, unveiled the first SDK built to power healthcare AI assistants with clean, connected, real-time health data and to provide self-service features that let individuals take action through conversational AI. As organizations race to deploy consumer-facing AI chat and agent experiences, the now-ava
Careverse announced the launch of the world's first AI Operating System for All Care, a platform designed to give providers their own AI agent, global reach, and independence from systems that have limited patient care for decades. For the first time, Careverse invites providers across all disciplines to become founding co-owners through its public fundraising Wefunder campaign.
Aidoc, the leading clinical AI platform, announced strategic partnerships with Cercare Medical and Circle CVI to expand its neurosciences portfolio with advanced MR Perfusion and automated ASPECTS (Alberta Stroke Program Early CT Score), two valuable capabilities for stroke and complex neuro care. These partnerships advance Aidoc's mission to connect fragmented neuro workflows and accelerate high&
Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, announced a collaboration with Daiichi Sankyo (TSE: 4568) that aims to accelerate biomarker discovery and optimize translational research by integrating multiple AI-powered Lunit SCOPE digital pathology products across two oncology pipeline programs. Daiichi Sankyo will apply various Lunit SCOPE solutions,
In their ongoing commitment to support clinicians at the point of care, EBSCO Clinical Decisions and Micromedex announced that Dyna AI for DynaMedex® will soon deliver expanded drug content and medication dosing information directly within the platform. This enhancement solidifies DynaMedex as a preeminent single destination for clinicians' clinical and medic
By subscribing, you agree to receive email related to content and products. You unsubscribe at any time.
Copyright 2026, AI Reporter America All rights reserved.
